Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients

Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients

Introduction: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve cardiovascular prognosis in patients with chronic kidney disease (CKD), diabetes, and heart failure; and slow the decline of kidney dysfunction in patients with albuminuria. Although safety and efficacy of SGLT2i have not been...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucie Maigret, Lucile Basle, Valérie Chatelet, Laure Ecotiere, Peggy Perrin, Léonard Golbin, Dominique Bertrand, Dany Anglicheau, Coralie Poulain, Cyril Garrouste, Clément Danthu, Charlotte Boud'hors, Yannick Le Meur, Manon Dekeyser, Fabien Duthe, Bénédicte Sautenet, Pierre-Guillaume Deliège, Philippe Gatault
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Kidney International Reports
Subjects:
proteinuria
renal transplantation
sodium-glucose cotransporters-2 inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924020552
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items